Vascular changes in bleomycin-induced scleroderma

International Journal of Rheumatology

Volumn 2011, Issue , 2011, Pages

  Yamamoto, Toshiyuki ^a   Katayama, Ichiro ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

BLOOD VESSEL INJURY; DISEASE MODEL; DRUG INDUCED DISEASE; ENDOTHELIUM CELL; FIBROBLAST; IMMUNOPATHOLOGY; MOUSE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; REVIEW; SCLERODERMA; SKIN FIBROSIS; SMOOTH MUSCLE FIBER; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

EID: 84855281414     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2011/270938     Document Type: Review

References (40)

1. Yamamoto T., Sclerodermapathophysiology European Journal of Dermatology 2009 19 1 14 24
2. Yamamoto T., Animal model of systemic sclerosis Journal of Dermatology 2010 37 1 26 41
3. Gabrielli A., Avvedimento E. V., Krieg T., Mechanisms of disease: scleroderma The New England Journal of Medicine 2009 360 19 1989 2003
4. Baroni S. S., Santillo M., Bevilacqua F., Luchetti M., Spadoni T., Mancini M., Fraticelli P., Sambo P., Funaro A., Kazlauskas A., Avvedimento E. V., Gabrielli A., Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis The New England Journal of Medicine 2006 354 25 2667 2676
5. Mihai C., Tervaert J. W. C., Anti-endothelial cell antibodies in systemic sclerosis Annals of the Rheumatic Diseases 2010 69 2 319 324
6. Kuwana M., Okazaki Y., Yasuoka H., Kawakami Y., Ikeda Y., Defective vasculogenesis in systemic sclerosis The Lancet 2004 364 9434 603 610 (Pubitemid 39094178)
7. Papa N. D., Quirici N., Soligo D., Scavullo C., Cortiana M., Borsotti C., Maglione W., Comina D. P., Vitali C., Fraticelli P., Gabrielli A., Cortelezzi A., Lambertenghi-Deliliers G., Bone marrow endothelial progenitors are defective in systemic sclerosis Arthritis and Rheumatism 2006 54 8 2605 2615 (Pubitemid 44205023)
8. Horstmeyer A., Licht C., Scherr G., Eckes B., Krieg T., Signalling and regulation of collagen I synthesis by ET-1 and TGF- 1 FEBS Journal 2005 272 24 6297 6309 (Pubitemid 41815618)
9. Shi-Wen X., Denton C. P., Dashwood M. R., Holmes A. M., Bou-Gharios G., Pearson J. D., Black C. M., Abraham D. J., Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1 Journal of Investigative Dermatology 2001 116 3 417 425 (Pubitemid 32202907)
10. Shephard P., Hinz B., Smola-Hess S., Meister J. J., Krieg T., Smola H., Dissecting the roles of endothelin, TGF- and GM-CSF on myofibroblast differentiation by keratinocytes Thrombosis and Haemostasis 2004 92 2 262 274 (Pubitemid 39172306)
11. Vancheeswaran R., Magoulas T., Efrat G., Wheeler-Jones C., Olsen I., Penny R., Black C. M., Circulating endothelin-1 levels in systemic sclerosis subsets-A marker of fibrosis or vasular dysfunction? Journal of Rheumatology 1994 21 10 1838 1844 (Pubitemid 24312644)
12. Shi-Wen X., Chen Y., Denton C. P., Eastwood M., Renzoni E. A., Bou-Gharios G., Pearson J. D., Dashwood M., Du Bois R. M., Black C. M., Leask A., Abraham D. J., Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts Molecular Biology of the Cell 2004 15 6 2707 2719 (Pubitemid 38691860)
13. Korn J. H., Mayes M., Matucci Cerinic M., Rainisio M., Pope J., Hachulla E., Rich E., Carpentier P., Molitor J., Seibold J. R., Hsu V., Guillevin L., Chatterjee S., Peter H. H., Coppock J., Herrick A., Merkel P. A., Simms R., Denton C. P., Furst D., Nguyen N., Gaitonde M., Black C., Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist Arthritis and Rheumatism 2004 50 12 3985 3993 (Pubitemid 39643947)
14. Kuhn A., Haust M., Ruland V., Weber R., Verde P., Felder G., Ohmann C., Gensch K., Ruzicka T., Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial Rheumatology 2010 49 7 1336 1345
15. Hirata Y., Emori T., Eguchi S., Kanno K., Imai T., Ohta K., Marumo F., Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells Journal of Clinical Investigation 1993 91 4 1367 1373 (Pubitemid 23127334)
16. Yamamoto T., Katayama I., Nishioka K., Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis Journal of Rheumatology 1998 25 2 314 317 (Pubitemid 28088261)
17. Takagi K., Kawaguchi Y., Hara M., Sugiura T., Harigai M., Kamatani N., Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features Clinical and Experimental Immunology 2003 134 3 538 544 (Pubitemid 37542097)
18. Beyer C., Schett G., Gay S., Distler O., Distler J. H., Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis Arthritis Research Therapy 2009 11 2 220
19. Sambo P., Jannino L., Candela M., Salvi A., Donini M., Dusi S., Luchetti M. M., Gabrielli A., Monocytes of patients with systemic sclerosis (scleroderma) spontaneously release in vitro increased amounts of superoxide anion Journal of Investigative Dermatology 1999 112 1 78 84 (Pubitemid 29024710)
20. Sambo P., Baroni S. S., Luchetti M., Paroncini P., Dusi S., Orlandini G., Gabrielli A., Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway Arthritis and Rheumatism 2001 44 11 2653 2664 (Pubitemid 33049343)
21. Murrell G. A. C., Francis M. J. O., Bromley L., Modulation of fibroblast proliferation by oxygen free radicals Biochemical Journal 1990 265 3 659 665 (Pubitemid 20053867)
22. Falanga V., Martin T. A., Takagi H., Kirsner R. S., Helfman T., Pardes J., Ochoa M. S., Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts Journal of Cellular Physiology 1993 157 2 408 412 (Pubitemid 23332786)
23. Casciola-Rosen L., Wigley F., Rosen A., Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis Journal of Experimental Medicine 1997 185 1 71 79 (Pubitemid 27039442)
24. Galindo M., Santiago B., Alcami J., Rivero M., Martn-Serrano J., Pablos J. L., Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts Clinical and Experimental Immunology 2001 123 1 36 41 (Pubitemid 32118834)
25. Yamamoto T., Bleomycin and the skin British Journal of Dermatology 2006 155 5 869 875 (Pubitemid 44564492)
26. Yamamoto T., Eckes B., Krieg T., Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts Archives of Dermatological Research 2000 292 11 556 561 (Pubitemid 32003039)
27. Phan S. H., Gharaee-Kermani M., Wolber F., Ryan U. S., Stimulation of rat endothelial cell transforming growth factor- production by bleomycin Journal of Clinical Investigation 1991 87 1 148 154
28. Yamamoto T., Takagawa S., Katayama I., Yamazaki K., Hamazaki Y., Shinkai H., Nishioka K., Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma Journal of Investigative Dermatology 1999 112 4 456 462 (Pubitemid 29171935)
29. Yamamoto T., Takahashi Y., Takagawa S., Katayama I., Nishioka K., Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(v) mice Journal of Rheumatology 1999 26 12 2628 2634
30. Yamamoto T., Kuroda M., Nishioka K., Animal model of sclerotic skin. III: histopathological comparison of bleomycin-induced scleroderma in various mice strains Archives of Dermatological Research 2000 292 11 535 541 (Pubitemid 32003036)
31. Yamamoto T., Nishioka K., Animal model of sclerotic skin. IV: induction of dermal sclerosis by bleomycin is T cell independent Journal of Investigative Dermatology 2001 117 4 999 1001 (Pubitemid 33001228)
32. Yamamoto T., Nishioka K., Animal model of sclerotic skin. V: increased expression of -smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma Clinical Immunology 2002 102 1 77 83 (Pubitemid 34095227)
33. Yamamoto T., Nishioka K., Animal model of sclerotic skin. VI: evaluation of bleomycin-induced skin sclerosis in nude mice Archives of Dermatological Research 2004 295 10 453 456 (Pubitemid 38468669)
34. Laplante P., Raymond M. A., Gagnon G., Vigneault N., Sasseville A. M. J., Langelier Y., Bernard M., Raymond Y., Hébert M. J., Novel fibrogenic pathways are activated in response to endothelial apoptosis: implications in the pathophysiology of systemic sclerosis Journal of Immunology 2005 174 9 5740 5749 (Pubitemid 40593217)
35. Jelaska A., Korn J. H., Role of apoptosis and transforming growth factor 1 in fibroblast selection and activation in systemic sclerosis Arthritis and Rheumatism 2000 43 10 2230 2239
36. Santiago B., Galindo M., Rivero M., Pablos J. L., Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts Arthritis and Rheumatism 2001 44 7 1667 1676 (Pubitemid 32642230)
37. Mungunsukh O., Griffin A. J., Lee Y. H., Day R. M., Bleomycin induces the extrinsic apoptotic pathway in pulmonary endothelial cells American Journal of Physiology 2010 298 5 L696 L703
38. Yamamoto T., Nishioka K., Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma Journal of Investigative Dermatology 2004 122 1 44 50 (Pubitemid 38114637)
39. Ishii H., Takada K., Bleomycin induces E-selectin expression in cultured umbilical vein endothelial cells by increasing its mRNA levels through activation of NF- B/Rel Toxicology and Applied Pharmacology 2002 184 2 88 97 (Pubitemid 35333897)
40. Templeton S. F., Solomon A. R., Swerlick R. A., Intradermal bleomycin injections into normal human skin: a histopathologic and immunopathologic study Archives of Dermatology 1994 130 5 577 583 (Pubitemid 24150935)